MedBright AI Appointments Brandon Kou as Director

Rhea-AI Summary

MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF) has appointed Brandon Kou as Director, effective February 3, 2025, replacing Jaime Gerber. Kou brings significant experience as Managing Director at Wildcat Equity Partners and former CEO of Leef Brands, where he led multiple acquisitions and a major merger in California. His background includes co-founding Block Partners and Mavan Capital Partners, as well as managing Steve Nash Enterprises' portfolio of companies.

Kou's expertise spans M&A, public markets, and investment banking, with previous experience at Houlihan Lokey and a degree from USC's Marshall School of Business. The company has granted 1,250,000 options to directors and officers at $0.035 with a five-year term.

Positive

• Appointment of experienced director with strong M&A and capital markets background
• New director brings relevant experience in healthcare, technology, and public markets
• Previous success in leading company acquisitions and mergers as CEO

Negative

• None.

VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) is pleased to announce that Brandon Kou has joined MedBright AI as a Director, effective February 3, 2025, replacing Jaime Gerber.

Brandon Kou is a Managing Director at Wildcat Equity Partners, a family office based in the US investing in healthcare, media, technology, and infrastructure.

Previously, he was CEO and board member of Leef Brands, a publicly traded MSO (multi-state operator) in the legalized cannabis space. Under his guidance, Leef acquired multiple brands and companies leading to an eventual merger with one of the largest manufactures in the state of California. Mr. Kou was responsible for all aspects of the business including M&A, all public market activities and general strategy for the company taking it from a small single brand focused company to one of the largest operators in the US.

Mr. Kou co-founded Block Partners, a merchant banking and advisory group for blockchain and distributed ledger technology companies. He also co-founded Mavan Capital Partners, an investment firm focused on bringing technology opportunities to the Canadian capital markets.

Earlier, Mr. Kou was Co-Founder and General Manager of Steve Nash Enterprises, managing a portfolio of companies in media/entertainment, sports, and health/wellness, including Indochino, Sharecare, the Vancouver Whitecaps, Onebode and the Steve Nash Sports Club and Fitness World. He also ran Meathawk, a film production company. In addition to his responsibilities at Steve Nash Enterprises, Mr. Kou served as a Board of Directors proxy for Steve Nash Sports Club and Fitness World, a growing chain fitness clubs in Vancouver co-founded by Mark Mastrov. 

Mr. Kou's background includes investment banking at Houlihan Lokey, and he brings strong knowledge and experience within the capital markets. He holds a degree from USC's Marshall School of Business.

The Company announces that 1,250,000 options have been granted to certain directors and officers at $0.035 for five years.

The Company expresses appreciation to Dr. Jamie Gerber for his contribution and wishes him the best in his future endeavours.

About MedBright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in diversified industries, including technology, health care and artificial intelligence. These include both public and private companies. Medbright has a focus on near-term and midterm high-quality opportunities with strong return potentials while maintaining its commitment to governance.

For further information, please contact:

MedBright AI Investments Inc.
Mr. Christopher Cherry, Interim Chief Executive Officer
Email: investors@medbright.ai
Phone: (604) 602-0001
www.medbright.ai

FAQ

Who is the new director appointed to MedBright AI (MBAIF) in February 2025?

Brandon Kou was appointed as Director of MedBright AI (MBAIF) effective February 3, 2025, replacing Jaime Gerber.

What stock options did MedBright AI (MBAIF) grant in February 2025?

MedBright AI granted 1,250,000 options to certain directors and officers at $0.035 per share with a five-year term.

What is Brandon Kou's current role besides being director at MedBright AI (MBAIF)?

Brandon Kou serves as Managing Director at Wildcat Equity Partners, a family office investing in healthcare, media, technology, and infrastructure.

What was Brandon Kou's major achievement as CEO of Leef Brands before joining MBAIF?

As CEO of Leef Brands, Kou led multiple acquisitions and successfully merged the company with one of the largest manufacturers in California.